1. Aguesse, S., Wang, Z., Boulay, A., Dannaoui, E., Borel, C., Schinazi, R., Cheng, Y.C., Trépo, C., Zoulim, F., 1997. An in vitro assay for the determination of the mechanism of inhibition of hepatitis B virus replication by nucleoside analogs and non nucleoside inhibitors. Viral hepatitis and liver disease. In: Rizzetto, M., Purcell, R.H., Gerin, J.L., Verme, G. (Eds.), Proceedings of the IX International Symposium of Viral Hepatitis and Liver Disease, Rome, April 1996, Edizioni Minerva Medica, Turin, pp. 152–156.
2. Inhibitory effect of 2′-fluoro-5-methyl-β-l-arabinofuranosyl-uracyl on duck hepatitis B virus replication;Aguesse-Germon;Antimicrob. Agents. Chemother.,1998
3. Aguesse-Germon, S., Seignères, B., Pichoud, C., Trépo, C., Zoulim, F., 1999. Replication capacity and sensitivity to nucleoside analogs of duck hepatitis B virus polymerase mutants of the YMDD motif (submitted for publication).
4. Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice;Akbar;J. Hepatol.,1997
5. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells [In Process Citation];Akbar;J. Hepatol.,1999